Circular RNA hsa_circ_0002360 Promotes Proliferation and Invasion and Inhibits Oxidative Stress in Gastric Cancer by Sponging miR-629-3p and Regulating the PDLIM4 Expression

Abstract

Many studies have found that circRNA hsa_0002360 (circ0002360) plays an important role in cancer onset and progression. However, its role in gastric cancer (GC) remains uncertain. Circ0002360 was found to be upregulated in GC cells using QRT-PCR. Furthermore, miR-629-3p, a target miRNA of circ0002360, was the most suppressed miRNA following circ0002360 overexpression. RNA immunoprecipitation (RIP), dual-luciferase reporter analyses, clone formation, transwell, DCFH-DA, and ELISA assays demonstrated that circ0002360-targeted miR-629-3p promotes cell proliferation and migration while inhibiting oxidative stress. GC-related mRNA microarrays from the GEO and TCGA databases, including GSE103236, GSE79973, GSE33429, GSE22804, GSE84437, and TCGA-STAD datasets, were used to find hub biomarkers between normal and gastric cancer samples. WGCNA and uni-Cox analysis were used to identify 27 survival-related risk genes, which were then used to build a risk model for prognosis prediction. Following that, all patients from the GSE84437 and TCGA-STAD datasets with 27 survival-related genes and enough data on survival status and time were randomly assigned to train ( n = 433 ) and test ( n = 375 ) cohorts. Furthermore, ROC and Kaplan-Meier (KM) analyses were used to validate the risk model for both cohorts. randomForest analysis indicated that PDLIM4 was the target gene of miR-629-3p, whose level was increased by circ0002360 but reversed by miR-629-3p mimics. Finally, this study confirmed that circ0002360 sponged miR-629-3p and then upregulated PDLIM4 expression. As a result, circ0002360 may be a useful marker for predicting GC prognosis and an anti-GC treatment target.

Modification of erythrocytes by internalizing Arg-Gly-Asp (iRGD) in boosting the curative effect of radiotherapy for gastric carcinoma

“…In recent years, a considerable amount of research on the resistance and sensitization of tumor RT, chemotherapy, immunotherapy, and targeted therapy has emerged, especially in the field of nanomaterials and small biological molecules (23)(24)(25)(26). In our team's previous work, we successfully constructed the recombinant protein iRGD- antiCD3 and demonstrated its antitumor efficacy by promoting T cell activation and infiltration.…”

The ctDNA-based postoperative molecular residual disease status in different subtypes of early-stage breast cancer

“…Currently, breast cancer is classified into different molecular subtypes, which have great significance for individualized intervention and prognostic prediction (2,28,29). Different molecular subtypes were also associated with anti-tumor treatment resistance in advanced cancers (30)(31)(32).…”

Machine learning-based integration develops an immune-related risk model for predicting prognosis of high-grade serous ovarian cancer and providing therapeutic strategies

“…Consensus clustering was carried out using the “ConsensusClusterPlus” package to identify TME-related subtypes for additional investigation in accordance with the infiltration of immune and stromal cells ( 30 ). Using the limma package ( 31 ), the differentially expressed genes (DEGs) between various immune subtypes were screened with an adjusted P < 0.05. TME-related genes of HGSOC were defined as genes that are co-upregulated or co-downregulated in not fewer than six cohorts.…”